1. 1801 Neoadjuvant chemotherapy with trastuzumab or lapatinib: Survival analysis of the HER2-positive cohort of the GeparQuinto study (GBG 44). (September 2015) Authors: Untch, M.; Von Minckwitz, G.; Gerber, B.; Eidtmann, H.; Rezai, M.; Fasching, P.A.; Tesch, H.; Eggemann, H.; Schrader, I.; Kittel, K.; Hanusch, C.; Huober, J.; Solbach, C.; Jackisch, C.; Kunz, G.; Blohmer, J.; Hauschild, M.; Fehm, T.; Nekljudova, V.; Loibl, S. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S264 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. COUNSELLING AND GENETIC TESTING FOR BREAST AND OVARIAN CANCER SUSCEPTIBILITY – THE GERMAN MODEL. Issue 1 (1st March 2003) Authors: Ditsch, N. C.; Nestle-Kraemling, C.; Bauerfeind, I.; Schmidt, D.; Straub, J.; Vodermaier, A.; Meindl, A.; Untch, M. Journal: International journal of gynecological cancer Issue: Volume 13:Issue 1(2003) Supplement Page Start: 88 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cytokine identification in seroma fluid after mastectomy in breast cancer patients – first results of SerMa pilot study subgroup. (November 2022) Authors: Ditsch, N.; Pochert, N.; Schneider, M.; Köpke, M.; Mattmer, A.; Hunstiger, S.; Sagasser, J.; Kahl, H.; Metz, A.; Reiger, M.; Neumann, A.; Banys-Paluchowski, M.; Untch, M.; Dannecker, C.; Jeschke, U.; Traidl-Hoffmann, C.; Kühn, T. Journal: European journal of cancer Issue: Volume 175(2022)Supplement 1 Page Start: S86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. DECISION FACTORS FOR PROPHYLACTIC MASTECTOMY AND OOPHORECTOMY IN HIGH RISK WOMEN FOR BREAST AND OVARIAN CANCER SUSCEPTIBILITY. Issue 1 (1st March 2003) Authors: Vodermaier, A.; Wagner, S.; Straub, J.; Ditsch, N.; Nestle-Kraemling, C.; Schmidt, D.; Meindl, A.; Untch, M. Journal: International journal of gynecological cancer Issue: Volume 13:Issue 1(2003) Supplement Page Start: 28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Gene expression profile at week 2 of neoadjuvant therapy course predicts outcome in HER2-positive breast cancer patients: an explorative analysis from NeoALTTO. (November 2022) Authors: Di Cosimo, S.; Pizzamiglio, S.; Sotiriou, C.; Ciniselli, C.M.; Triulzi, T.; de Cecco, L.; El-Abed, S.; Izquierdo, M.; de Azambuja, E.; Saura, C.; Huober, J.; Untch, M.; Lang, I.; Loi, S.; Tagliabue, E.; Rubio, I.T.; Vingiani, A.; Colombo, M.P.; Verderio, P.; Pruneri, G. Journal: European journal of cancer Issue: Volume 175(2022)Supplement 1 Page Start: S78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. German Adjuvant Intergroup Node-positive Study (GAIN): a phase III trial comparing two dose-dense regimens (iddEPC versus ddEC-PwX) in high-risk early breast cancer patients. (28th April 2017) Authors: Möbus, V.; von Minckwitz, G.; Jackisch, C.; Lück, H.-J.; Schneeweiss, A.; Tesch, H.; Elling, D.; Harbeck, N.; Conrad, B.; Fehm, T.; Huober, J.; Müller, V.; Bauerfeind, I.; du Bois, A.; Loibl, S.; Nekljudova, V.; Untch, M.; Thomssen, C. Journal: Annals of oncology Issue: Volume 28:Number 8(2017) Page Start: 1803 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Implant-based Mesh Supported Breast Reconstruction: Patient Reported Outcome Data (PRO-BRA trial, TiLOOP® Bra) and Perspectives. (April 2018) Authors: Paepke, S.; Klein, E.; Kiechle, M.; Ankel, C.; Faridi, A.; Schumacher, C.; Meiré, A.; Blohmer, J.U.; Untch, M.; Mau, C.; Ohlinger, R.; Strittmatter, H.J.; Thill, M. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 3 Page Start: S87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Magnetic resonance imaging for prediction of pathologic response to neoadjuvant chemotherapy in triple-negative breast cancer. Issue 2 (February 2019) Authors: Golshan, M.; Wong, S.; Loibl, S.; Huober, J.B.; O'Shaughnessy, J.; Rugo, H.S.; Wolmark, N.; McKee, M.D.; Maag, D.; Sullivan, D.M.; Metzger-Filho, O.; Von Minckwitz, G.; Geyer, C.E.; Sikov, W.M.; Untch, M. Journal: European journal of surgical oncology Issue: Volume 45:Issue 2(2019) Page Start: e12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P125 Neoadjuvant pembrolizumab + chemotherapy vs placebo + chemotherapy followed by adjuvant pembrolizumab vs placebo for early TNBC: surgical outcomes from the phase 3 KEYNOTE-522 study. (April 2023) Authors: Kümmel, S.; Schmid, P.; Harbeck, N.; Takahashi, M.; Untch, M.; Boileau, J.-F.; Cortes, J.; McArthur, H.; Dent, R.; O'Shaughnessy, J.; Pusztai, L.; Foukakis, T.; Park, Y.H.; Hui, R.; Cardoso, F.; Denkert, C.; Zhu, Y.; Pan, W.; Karantza, V.; Fasching, P. Journal: Breast Issue: Volume 68(2023)Supplement Page Start: S63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. SURGICAL OUTCOME AFTER PRIMARY SYSTEMIC CHEMOTHERAPY - RESULTS OF THE RANDOMISED DOSE DENSE AGO-STUDY (MUNICH PROTOCOL). Issue 1 (1st March 2003) Authors: Bauerfeind, I.; Nestle-Kramling, C.; Kahlert, S.; Ditsch, N.; Hasmuller, S.; Untch, M. Journal: International journal of gynecological cancer Issue: Volume 13:Issue 1(2003) Supplement Page Start: 3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗